November 3 in NYC: “Cell Division: From Molecular Machines to Human Disease”

Join us for a special presentation and cocktail reception with Whitehead Member Iain Cheeseman, PhD. What: “Cell […]


Whitehead’s Jing-Ke Weng receives 2016 Beckman Young Investigator Award

Whitehead Member Jing-Ke Weng is one of eight early-career scientists nationwide to be named a 2016 Beckman […]


Engineers design programmable RNA vaccines against ebola, influenza

MIT and Whitehead Institute scientists have developed a new type of easily customizable vaccine that can be […]

2016 colloquium

2016 Whitehead Colloquium on Saturday, October 15

Please join us for the 2016 Whitehead Colloquium on Saturday, October 15. The 2016 Whitehead Colloquium, moderated […]

Susan Lindquist

Whitehead Member Susan Lindquist to receive prestigious Albany Prize in Medicine

Whitehead Institute Member Susan Lindquist has been named one of three recipients of the Albany Medical Center […]

Deborah Dunsire photo

Whitehead Connects presents Deborah Dunsire

“Making Medicines: The Ultimate Team Sport” Deborah Dunsire, MD Former President and CEO, FORUM Pharmaceuticals September 20, […]

September 13 at Whitehead Institute: “Beyond the Human Genome Project: New Elements in Tumorigenesis”

Join us for a special presentation and cocktail reception with Whitehead Faculty Member Richard A. Young, PhD […]

Human lung cells were infected with influenza A virus. In unmodified cells (left) and cells expressing an irrelevant VHH control (middle), influenza A virus genome segments decorated with nucleoprotein NP (green) accumulate in the nucleus (blue), where virus replciation takes place. If expressed in cells, the antiviral VHH 508 (right) prevents nuclear import of viral genomes. Cells expressing VHH are stained in red.

Tiny alpaca-derived antibodies point to targets preventing viral infection

Whitehead Institute scientists have determined how to use alpaca-derived, single-domain antibody fragments (also called VHHs or nanobodies) […]